Saturday, November 15, 2025

Joseph Poschet

written articles

Copper’s Segmented Surge and a Junior Explorer in Focus

The global copper market is undergoing a meaningful transition. As the world accelerates electrification, renewable energy infrastructure, and digital connectivity, copper demand continues to...

Copper Quest – September 2025

https://poschevale.com/general-research-disclaimer/

Oil, Artificial Intelligence, and the Future of Energy

Artificial intelligence has rapidly emerged as one of the defining technologies of the twenty-first century, driving advances in data analysis, automation, and decision-making. Behind...

Oregen Energy – September 2025

https://poschevale.com/general-research-disclaimer/

Copper Quest: A Rising Star in North America’s Critical Minerals Boom

In an era where the global transition to green energy is accelerating at breakneck speed, copper stands out as the indispensable metal powering everything...

NexGen Energy’s Momentum Builds: Key Advances in Uranium Exploration and Sales Amid Global Energy Shift

In the rapidly evolving landscape of clean energy, NexGen Energy Ltd. continues to position itself as a pivotal player in the uranium sector. As...

Oregen’s Strategic Moves in Namibia’s Oil Boom

Namibia’s offshore Orange Basin has rapidly emerged as one of the world’s most promising oil exploration frontiers, driven by its substantial hydrocarbon potential and...

Fueling Innovation: Canadian Healthcare Small-Caps Secure Key 2025 Financings

In 2025, a wave of Canadian healthcare companies have successfully raised fresh capital through private placements exceeding C$2.5 million, a sign of robust investor appetite...

Canadian Junior Explorers Under $1 Fuel Up for Development

Canadian-listed junior exploration companies trading below CA$1.00 per share have leveraged strong investor interest in the past six months, completing substantial financings (over CA$5...

RenovoRx: Pioneering Targeted Drug Delivery in Oncology

RenovoRx, Inc. (Nasdaq: RNXT), headquartered in California, is a clinical-stage biopharmaceutical company that is pioneering the use of targeted intra-arterial chemotherapy for treating solid...

Explore more